Advertisement
Review Article| Volume 50, ISSUE 1, P183-203, March 2023

An Overview of Antiviral Treatments in Pregnancy

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marani M.
        • Katul G.G.
        • Pan W.K.
        • et al.
        Intensity and frequency of extreme novel epidemics.
        PNAS. 2021; 118 (e2105482118)
        • Vardanyan R.
        • Hruby V.
        Antiviral drugs.
        in: Vardanyan R. Hruby V. Synthesis of best-seller drugs. Elsevier, 2016: 687-736 (Copyright: © Academic Press 2016. Imprint: Academic Press)
        • Hazenberg P.
        • Navaratnam K.
        • Busuulwa P.
        • et al.
        Anti-Infective Dosing in Special Populations: Pregnancy.
        Clin Pharmacol Ther. 2021; 109: 977-986
        • Castelli M.S.
        • McGonigle P.
        • Hornby P.J.
        The pharmacology and therapeutic applications of monoclonal antibodies.
        Pharmacol Res Perspect. 2019; 7: e00535
        • Ballow M.
        Safety of IGIV therapy and infusion-related adverse events.
        Immunol Res. 2007; 38: 122-132
        • Pham-Huy A.
        • Sadarangani M.
        • Huang V.
        • et al.
        From mother to baby: antenatal exposure to monoclonal antibody biologics.
        Expert Rev Clin Immunol. 2019; 15: 221-229
        • Pham-Huy A.
        • Top K.A.
        • Constantinescu C.
        • et al.
        The use and impact of monoclonal antibody biologics during pregnancy.
        CMAJ. 2021; 193: E1129-E1136
        • Leruez-Ville M.
        • Foulon I.
        • Pass R.
        • et al.
        Cytomegalovirus infection during pregnancy: state of the science.
        Am J Obstet Gynecol. 2020; 223: 330-349
        • Hughes B.L.
        • Clifton R.G.
        • Rouse D.J.
        • et al.
        A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
        N Engl J Med. 2021; 385: 436-444
        • Fowler K.
        • Mucha J.
        • Neumann M.
        • et al.
        A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.
        BMC Public Health. 2022; 22: 1659
        • Griffiths P.
        • Reeves M.
        Pathogenesis of human cytomegalovirus in the immunocompromised host.
        Nat Rev Microbiol. 2021; 19: 759-773
        • Royal College of Obstetricians and Gynecologists
        Congenital Cytomegalovirus Infection: Update on Treatment.
        BJOG. 2018; 125: e1-e11
        • Acosta E.
        • Bowlin T.
        • Brooks J.
        • et al.
        Advances in the development of therapeutics for cytomegalovirus infections.
        J Infect Dis. 2020; 221: 32-44
        • Crumpacker C.S.
        Ganciclovir.
        N Engl J Med. 1996; 335: 721-729
        • Shahar-Nissan K.
        • Pardo J.
        • Peled O.
        • et al.
        Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
        Lancet. 2020; 396: 779-785
        • Leruez-Ville M.
        • Ghout I.
        • Bussières L.
        • et al.
        In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
        Am J Obstet Gynecol. 2016; 215: 462.e1-10
        • Nigro G.
        • Adler S.P.
        • la Torre R.
        • et al.
        Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection.
        N Engl J Med. 2005; 353: 1350-1362
        • Revello M.G.
        • Lazzarotto T.
        • Guerra B.
        • et al.
        A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus.
        N Engl J Med. 2014; 370: 1316-1326
        • Kagan K.O.
        • Enders M.
        • Schampera M.S.
        • et al.
        Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
        Ultrasound Obstet Gynecol. 2019; 53: 383-389
        • Feldmann H.
        • Sprecher A.
        • Geisbert T.W.
        Ebola N Engl J Med. 2020; 382: 1832-1842
        • WHO Ebola Response Team
        Ebola Virus Disease in West Africa-The First 9 Months of the Epidemic and Forward Projections.
        N Engl J Med. 2014; 371: 1481-1495
        • Akerlund E.
        • Prescott J.
        • Tampellini L.
        Shedding of Ebola Virus in an Asymptomatic Pregnant Woman.
        N Engl J Med. 2015; 372: 2467-2469
        • Jamieson D.J.
        • Uyeki T.M.
        • Callaghan W.M.
        • et al.
        What obstetrician-gynecologists should know about ebola: A perspective from the centers for disease control and prevention.
        Obstet Gynecol. 2014; 124: 1005-1010
        • Ratcliffe R.
        Safe birth of baby born to Ebola survivor hailed as a medical miracle Daughter of Congolese woman treated for Ebola in December becomes only second healthy child born in such circumstances.
        • World Health Organization
        Therapeutics for Ebola Virus Disease.
        (Available at:) (Accessed September 8, 2022)
        • World Health Organization
        Hepatitis B.
        • Tang L.S.Y.
        • Covert E.
        • Wilson E.
        • et al.
        Chronic Hepatitis B infection a review.
        JAMA - J Am Med Assoc. 2018; 319: 1802-1813
        • Owens D.K.
        • Davidson K.W.
        • Krist A.H.
        • et al.
        Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.
        JAMA. 2019; 322: 349-354
        • Jonas M.M.
        Hepatitis B and pregnancy: An underestimated issue.
        Liver Int. 2009; 29: 133-139
        • Dionne-Odom J.
        • Cozzi G.D.
        • Franco R.A.
        • et al.
        Treatment and prevention of viral hepatitis in pregnancy.
        Am J Obstet Gynecol. 2022; 226: 335-346
        • Shepard C.
        • Finelli L.
        • Bell B.
        • et al.
        Acute Hepatitis B Among Children and Adolescents—United States, 1990-2002.
        J Am Med Assoc. 2004; 292: 2967-2968
        • Funk A.L.
        • Lu Y.
        • Yoshida K.
        • et al.
        Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
        Lancet Infect Dis. 2021; 21: 70-84
        • Gallant J.E.
        • Daar E.S.
        • Raffi F.
        • et al.
        Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.
        Lancet HIV. 2016; 3: e158-e165
        • Pan C.Q.
        • Duan Z.
        • Dai E.
        • et al.
        Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
        N Engl J Med. 2016; 374: 2324-2334
        • Prabhu M.
        • Susich M.K.
        • Packer C.H.
        • et al.
        Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
        Obstet Gynecol. 2022; 139: 357-367
        • Centers for Disease Control and Prevention
        CDC Recommendations for Hepatitis B Testing and Screening - United States, 2022.
        (Available at:) (Accessed August 21, 2022)
        • Siston A.M.
        • Rasmussen S.A.
        • Honein M.A.
        • et al.
        Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States.
        J Am Med Assoc. 2010; 303: 1517-1525
        • Mosby L.G.
        • Rasmussen S.A.
        • Jamieson D.J.
        2009 pandemic influenza A (H1N1) in pregnancy: A systematic review of the literature.
        Am J Obstet Gynecol. 2011; 205: 10-18
      1. Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza: ACOG Committee Opinion No. 753.
        Obstet Gynecol. 2018; 132: e169-e173
        • Patton M.E.
        • Bernstein K.
        • Liu G.
        • et al.
        Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women and sexually active, nonpregnant women in the United States.
        Clin Infect Dis. 2018; 67: 1535-1542
        • Whitley R.
        • Kimberlin D.W.
        • Prober C.G.
        Arvin A. Campadelli-Fiume G. Mocarski E. Chapter 32 pathogenesis and disease. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, 2007 (Available at:)
      2. Management of Genital Herpes in Pregnancy: ACOG Practice Bulletin No. 220.
        Obstet Gynecol. 2020; 135: e193-e202
        • Looker K.J.
        • Magaret A.S.
        • May M.T.
        • et al.
        First estimates of the global and regional incidence of neonatal herpes infection.
        Lancet Glob Health. 2017; 5: e300-e309
        • Brown Z.A.
        • Wald A.
        • Morrow M.R.A.
        • et al.
        Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to Infant.
        JAMA. 2003; 289: 203-209
        • Stone K.
        • Brooks C.
        • Guinan M.
        • et al.
        National surveillance for neonatal herpes simplex virus infections.
        Sex Transm Dis. 1989; 16: 152-156
        • James S.H.
        • Sheffield J.S.
        • Kimberlin D.W.
        Mother-to-child transmission of herpes simplex virus.
        J Pediatr Infect Dis Soc. 2014; 3: S19-S23
        • Kimberlin D.
        • Weller S.
        • Whitley R.
        • et al.
        Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
        Am J Obstet Gynecol. 1998; 179: 846-851
        • Frenkel L.
        • Brown Z.
        • Bryson Y.
        • et al.
        Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
        Am J Obstet Gynecol. 1991; 164: 569-576
        • Musso D.
        • Ko A.I.
        • Baud D.
        Zika Virus Infection — After the Pandemic.
        N Engl J Med. 2019; 381: 1444-1457
        • Mlakar J.
        • Korva M.
        • Tul N.
        • et al.
        Zika Virus Associated with Microcephaly.
        N Engl J Med. 2016; 374: 951-958
        • Paixao E.S.
        • Cardim L.L.
        • Costa M.C.N.
        • et al.
        Mortality from Congenital Zika Syndrome — Nationwide Cohort Study in Brazil.
        N Engl J Med. 2022; 386: 757-767
        • Avalos L.A.
        • Chen H.
        • Yang C.
        • et al.
        The Prevalence and Trends of Antiviral Medication Use During Pregnancy in the US: A Population-Based Study of 664,297 Deliveries in 2001-2007.
        Matern Child Health J. 2014; 18: 64-72